products

mapping key decision makers

A buying decision for medical technology is less likely to be the responsibility of an individual clinician in most markets these days. Our clients ask us to identify those key decision makers directly and indirectly influencing decisions on pathways or care and resource use. Translucency’s KDM® approach is tailored to answer your key questions about market size, likely market share, or speed of market penetration. For example:

• estimate the likely effect of price and/or positioning;
• identify the information that decision makers will expect to see when asked to make a decision to purchase or prescribe;
• clarify the factors that will be considered by payors in taking a buying decision so that you are can present your case in the most persuasive way.